225 related articles for article (PubMed ID: 31649514)
1. Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance.
Ethridge LE; De Stefano LA; Schmitt LM; Woodruff NE; Brown KL; Tran M; Wang J; Pedapati EV; Erickson CA; Sweeney JA
Front Integr Neurosci; 2019; 13():60. PubMed ID: 31649514
[TBL] [Abstract][Full Text] [Related]
2. Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome.
Ethridge LE; White SP; Mosconi MW; Wang J; Byerly MJ; Sweeney JA
Transl Psychiatry; 2016 Apr; 6(4):e787. PubMed ID: 27093069
[TBL] [Abstract][Full Text] [Related]
3. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.
Ethridge LE; White SP; Mosconi MW; Wang J; Pedapati EV; Erickson CA; Byerly MJ; Sweeney JA
Mol Autism; 2017; 8():22. PubMed ID: 28596820
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
5. Development of Neural Response to Novel Sounds in Fragile X Syndrome: Potential Biomarkers.
Ethridge L; Thaliath A; Kraff J; Nijhawan K; Berry-Kravis E
Am J Intellect Dev Disabil; 2020 Nov; 125(6):449-464. PubMed ID: 33211818
[TBL] [Abstract][Full Text] [Related]
6. Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome.
Razak KA; Binder DK; Ethell IM
Front Psychiatry; 2021; 12():720752. PubMed ID: 34690832
[TBL] [Abstract][Full Text] [Related]
7. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability.
Wilkinson CL; Nelson CA
Mol Autism; 2021 Feb; 12(1):17. PubMed ID: 33632320
[TBL] [Abstract][Full Text] [Related]
8. Neural response to repeated auditory stimuli and its association with early language ability in male children with Fragile X syndrome.
An WW; Nelson CA; Wilkinson CL
Front Integr Neurosci; 2022; 16():987184. PubMed ID: 36452884
[TBL] [Abstract][Full Text] [Related]
9. Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
Lovelace JW; Ethell IM; Binder DK; Razak KA
Front Neurosci; 2020; 14():771. PubMed ID: 32848552
[TBL] [Abstract][Full Text] [Related]
10. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.
Wang J; Ethridge LE; Mosconi MW; White SP; Binder DK; Pedapati EV; Erickson CA; Byerly MJ; Sweeney JA
J Neurodev Disord; 2017; 9():11. PubMed ID: 28316753
[TBL] [Abstract][Full Text] [Related]
11. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome.
Jonak CR; Lovelace JW; Ethell IM; Razak KA; Binder DK
Neurobiol Dis; 2020 May; 138():104794. PubMed ID: 32036032
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in resting EEG power in Fragile X Syndrome.
Smith EG; Pedapati EV; Liu R; Schmitt LM; Dominick KC; Shaffer RC; Sweeney JA; Erickson CA
J Psychiatr Res; 2021 Jun; 138():89-95. PubMed ID: 33836434
[TBL] [Abstract][Full Text] [Related]
13. Hemispheric Utilization of Alpha Oscillatory Dynamics as a Unique Biomarker of Neural Compensation in Females with Fragile X Syndrome.
Norris JE; DeStefano LA; Schmitt LM; Pedapati EV; Erickson CA; Sweeney JA; Ethridge LE
ACS Chem Neurosci; 2022 Dec; 13(23):3389-3402. PubMed ID: 36411085
[TBL] [Abstract][Full Text] [Related]
14. Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome.
Wen TH; Lovelace JW; Ethell IM; Binder DK; Razak KA
Neuroscience; 2019 Feb; 398():126-143. PubMed ID: 30528856
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric feature-based subgrouping reveals neural sensory processing spectrum in female FMR1 premutation carriers: A pilot study.
Norris JE; Schmitt LM; De Stefano LA; Pedapati EV; Erickson CA; Sweeney JA; Ethridge LE
Front Integr Neurosci; 2023; 17():898215. PubMed ID: 36816716
[TBL] [Abstract][Full Text] [Related]
16. Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome.
Ethridge LE; Pedapati EV; Schmitt LM; Norris JE; Auger E; De Stefano LA; Sweeney JA; Erickson CA
Res Sq; 2024 Jan; ():. PubMed ID: 38313274
[TBL] [Abstract][Full Text] [Related]
17. Sensory Processing Phenotypes in Fragile X Syndrome.
Rais M; Binder DK; Razak KA; Ethell IM
ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
[TBL] [Abstract][Full Text] [Related]
18. Frontal Cortex Hyperactivation and Gamma Desynchrony in Fragile X Syndrome: Correlates of Auditory Hypersensitivity.
Pedapati EV; Ethridge LE; Liu Y; Liu R; Sweeney JA; DeStefano LA; Miyakoshi M; Razak K; Schmitt LM; Moore DR; Gilbert DL; Wu SW; Smith E; Shaffer RC; Dominick KC; Horn PS; Binder D; Erickson CA
bioRxiv; 2024 Jun; ():. PubMed ID: 38915683
[TBL] [Abstract][Full Text] [Related]
19. Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome.
Jonak CR; Pedapati EV; Schmitt LM; Assad SA; Sandhu MS; DeStefano L; Ethridge L; Razak KA; Sweeney JA; Binder DK; Erickson CA
J Neurodev Disord; 2022 Sep; 14(1):52. PubMed ID: 36167501
[TBL] [Abstract][Full Text] [Related]
20. EEG as a translational biomarker and outcome measure in fragile X syndrome.
Kenny A; Wright D; Stanfield AC
Transl Psychiatry; 2022 Jan; 12(1):34. PubMed ID: 35075104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
